Error in Figure
In the original publication, there was an inadvertent labeling mistake in Figure 11A as published []. Figure 11A was mistakenly mislabeled as corresponding to the control group. In fact, it is a second image from the Rp-Nc 1 mg-treated group. This image was captured from the same sample as that shown in Figure 11D. As a result, there is a slight overlap in one corner of Figure 11A,D, since both represent the same treatment group. Because we were capturing images from different parts of the organs, unintentional mislabeling occurred. The corrected version of Figure 11 appears below.
Figure 11.
Photomicrographs of microsections of the pancreas of rats: (A) control group showing the normal histological structure of islets of Langerhans with normal pancreatic acini; (B) diabetic group showing ruptured and destroyed islets of Langerhans with damage in beta cells; and (C,D) Rp-Nc 0.5 mg- and 1 mg-treated groups showing some normal islets of Langerhans with some mild destruction in normal pancreatic ducts and in between normal pancreatic acini (H&E scale bar, 25 µm).
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Ahmad, M.; Khan, S.; Shah, S.M.H.; Zahoor, M.; Hussain, Z.; Hussain, H.; Shah, S.W.A.; Ullah, R.; Alotaibi, A. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).